Patients who underwent upper gastrointestinal endoscopy or colonoscopy at Keio University Hospital
Conditions
Interventions
None listed
Sponsors
Keio University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who underwent esophagogastroduodenoscopy or colonoscopy at Keio University Hospital
Exclusion criteria
Exclusion criteria: Cases in which there are obvious deficiencies in the content related to sedation and medical information such as vital signs before, during, and after gastrointestinal endoscopy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of adverse events (decrease in blood pressure, pulse rate, and SpO2) that occurred during sedation for gastrointestinal endoscopy | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) Presence/absence, type, and dosage of sedative medication during gastrointestinal endoscopy, antagonist (flumazenil) administration, and analgesic administration (2) Treatment (infusion of fluids, oxygen administration) for adverse events (decrease in blood pressure, decrease in heart rate, decrease in SpO2) (3) Falls in the hospital or on the way home (4) Length of stay in the recovery room (5) Patient's age, gender, underlying disease, medical history, and medications | — |
Countries
Japan
Contacts
Public ContactAtsushi Nakayama
Keio University Hospital Cancer Center
Outcome results
None listed